Foamix Pharmaceuticals Ltd. Additional Paid in Capital
Foamix Pharmaceuticals Ltd. had Additional Paid in Capital of $325.50 million as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2020-03-12
- 2019-12-31: Additional Paid in Capital $325.50M.
- 2019-09-30: Additional Paid in Capital $323.66M.
- 2019-06-30: Additional Paid in Capital $307.65M.
- 2019-03-31: Additional Paid in Capital $306.27M.
| Period end | Additional Paid in Capital |
|---|---|
| 2019-12-31 | $325.50M 10-K · filed 2020-03-12 |
| 2019-09-30 | $323.66M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $307.65M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $306.27M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $305.30M 10-K · filed 2020-03-12 |
| 2018-09-30 | $304.12M 10-Q · filed 2018-11-07 |
| 2018-06-30 | $228.15M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $210.12M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $208.36M 10-K · filed 2019-02-28 |
| 2017-06-30 | $205.67M 6-K · filed 2017-08-08 |
| 2016-12-31 | $204.05M 10-K · filed 2018-03-01 |
| 2016-06-30 | $147.11M 6-K · filed 2016-08-10 |
| 2015-12-31 | $145.88M 20-F · filed 2017-02-21 |
| 2015-06-30 | $144.78M 6-K · filed 2015-10-19 |
| 2014-12-31 | $77.60M 20-F · filed 2016-03-02 |
| 2013-12-31 | $14.18M 20-F · filed 2015-03-17 |